Efficacy and safety of the adjustable gastric band – pooled interim analysis of the APEX and HERO studies at 48 weeks

References

• Obesity and Overweight, Fact Sheet No 311, May 2012. World Health Organization. Available at: http://www.who.int/mediacentre/factsheets/fs311/en/index.html [Last accessed 11 February 2013]
   Google Scholar
• Flegal KM, Carroll MD, Kit BK, et al. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 2012;307:491-7
   PubMed Web of Science ®Google Scholar
• Wang Y, Beydoun MA, Liang L, et al. Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obesity (Silver Spring) 2008;16:2323-30
   PubMed Web of Science ®Google Scholar
• Fontaine KR, Redden DT, Wang C, et al. Years of life lost due to obesity. JAMA 2003;289:187-93
   PubMed Web of Science ®Google Scholar
• Fox CS, Pencina MJ, Wilson PW, et al. Lifetime risk of cardiovascular disease among individuals with and without diabetes stratified by obesity status in the Framingham heart study. Diabetes Care 2008;31:1582-4
   PubMed Web of Science ®Google Scholar
• Biggs ML, Mukamal KJ, Luchsinger JA, et al. Association between adiposity in midlife and older age and risk of diabetes in older adults. JAMA 2010;303:2504-12
   PubMed Web of Science ®Google Scholar
• Geiss LS, Pan L, Cadwell B, et al. Changes in incidence of diabetes in U.S. adults, 1997–2003. Am J Prev Med 2006;30:371-7
   PubMed Web of Science ®Google Scholar
• Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003;289:76-9
   PubMed Web of Science ®Google Scholar
• Hampel H, Abraham NS, El Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005;143:199-211
   PubMed Web of Science ®Google Scholar
• Herpertz S, Kielmann R, Wolf AM, et al. Does obesity surgery improve psychosocial functioning? A systematic review. Int J Obes Relat Metab Disord 2003;27:1300-14
   PubMed Web of Science ®Google Scholar
• Karlsson J, Taft C, Rydén A, et al. Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study. Int J Obes (Lond) 2007;31:1248-61
   PubMed Web of Science ®Google Scholar
• Mannucci E, Petroni ML, Villanova N, et al; QUOVADIS Study Group. Clinical and psychological correlates of health-related quality of life in obese patients. Health Qual Life Outcomes 2010;8:90 . doi: 10.1186/1477-7525-8-90
   PubMed Web of Science ®Google Scholar
• Gadde KM, Allison DB, Ryan DH, et al. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. Lancet 2011;377:1341-52
   PubMed Web of Science ®Google Scholar
• Norris SL, Zhang X, Avenell A, et al. Long-term non-pharmacologic weight loss interventions for adults with type 2 diabetes. Cochrane Database Syst Rev 2005;2:CD004095
   Google Scholar
• Rucker D, Padwal R, Li SK, et al. Long term pharmacotherapy for obesity and overweight: updated meta-analysis. BMJ 2007;335:1194-9
   PubMed Web of Science ®Google Scholar
• Mechanick JI, Kushner RF, Sugerman HJ, et al. American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Endo Pract 2008;14(Suppl 1):1-83
   Google Scholar
• Bariatric surgical and procedural interventions in the treatment of obese patients with type 2 diabetes: a position statement from the International Diabetes Federation taskforce on epidemiology and prevention (2011). Available at: http://www.idf.org/webdata/docs/IDF-Position-Statement-Bariatric-Surgery.pdf [Last accessed 12 February 2013]
   Google Scholar
• Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009;122:248-56
   PubMed Web of Science ®Google Scholar
• O’Brien PE, MacDonald L, Anderson M, et al. Long-term outcomes after bariatric surgery. Fifteen-year follow-up of adjustable gastric banding and a systematic review of the bariatric surgical literature. Ann Surg 2013;257:87-94
   PubMed Web of Science ®Google Scholar
• Hutter MM, Schirmer BD, Jones DB, et al. First report from the American College of Surgeons Bariatric Surgery Center Network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass. Ann Surg 2011;254:410-20
   PubMed Web of Science ®Google Scholar
• Flum DR, Belle SH, King WC, et al. Longitudinal Assessment of Bariatric Surgery (LABS) Consortium. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med 2009;361:445-54
   PubMed Web of Science ®Google Scholar
• Buchwald H, Williams SE. Bariatric surgery worldwide 2003. Obes Surg 2004;14:1157-64
   PubMed Web of Science ®Google Scholar
• Ray JB, Ray S. Safety, efficacy, and durability of laparoscopic adjustable gastric banding in a single surgeon U.S. community practice. Surg Obes Relat Dis 2011;7:140-4
   PubMed Web of Science ®Google Scholar
• Nguyen NT, Hohmann S, Nguyen XM, et al. Outcome of laparoscopic adjustable gastric banding and prevalence of band revision and explantation at academic centers: 2007–2009. Surg Obes Relat Dis 2012;8:724-7
   PubMed Web of Science ®Google Scholar
• Allergan Inc. LAP BAND AP system device label. Available at: http://www.allergan.com/assets/pdf/lapband_dfu.pdf [Last accessed 14 February 2013]
   Google Scholar
• Shayani V, Voellinger D, Liu C, et al. Safety and efficacy of the LAP-BAND AP adjustable gastric band in the treatment of obesity: results at 2 years. Postgrad Med 2012;124:181-8
   PubMed Web of Science ®Google Scholar
• Edelman S, Bhoyrul S, Billy H, et al. Effect of early weight loss on type 2 diabetes mellitus after 2 years of gastric banding. Postgrad Med 2012;124:73-81
   PubMed Web of Science ®Google Scholar
• Woodman G, Cywes R, Billy H, et al; APEX Study Group. Effect of adjustable gastric banding on changes in gastroesophageal reflux disease (GERD) and quality of life. Curr Med Res Opin 2012;28:581-9
   PubMed Web of Science ®Google Scholar
• Allison DB, Gadde KM, Garvey WT, et al. Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP). Obesity (Silver Spring) 2012;20:330-42
   PubMed Web of Science ®Google Scholar
• Watkins B, Cornell C, Okerson T. Number of visits (but not adjustments) is related to weight loss in gastric banding patients [abstract]. Obes Surg 2012;22:1379
   Web of Science ®Google Scholar
• Weichman K, Ren C, Kurian M, et al. The effectiveness of adjustable gastric banding: a retrospective 6-year U.S. follow-up study. Surg Endosc 2011;25:397-403
   PubMed Web of Science ®Google Scholar
• Valle E, Luu MB, Autajay K, et al. Frequency of adjustments and weight loss after laparoscopic adjustable gastric banding. Obes Surg 2012;22:1880-3
   PubMed Web of Science ®Google Scholar
• Knowler WC, Barrett-Connor E, Fowler SE, et al. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403
   PubMed Web of Science ®Google Scholar
• Gregg EW, Chen H, Wagenknecht LE, et al. Look AHEAD Research Group. Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA 2012;308:2489-96
   PubMed Web of Science ®Google Scholar
• Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364-79
   PubMed Web of Science ®Google Scholar
• Shukla AP, Ahn SM, Patel RT, et al. Surgical treatment of type 2 diabetes: the surgeon perspective. Endocrine 2011;40:151-61
   PubMed Web of Science ®Google Scholar
• Libeton M, Dixon JB, Laurie C, O’Brien PE. Patient motivation for bariatric surgery: characteristics and impact on outcomes. Obes Surg 2004;14:392-8
   PubMed Web of Science ®Google Scholar
• Residori L, García-Lorda P, Flancbaum L, et al. Prevalence of co-morbidities in obese patients before bariatric surgery: effect of race. Obes Surg 2003;13:333-40
   PubMed Web of Science ®Google Scholar
• O’Brien PE, McPhail T, Chaston TB, et al. Systematic review of medium-term weight loss after bariatric operations. Obes Surg 2006;16:1032-40
   PubMed Web of Science ®Google Scholar
• Strain GW, Saif T, Gagner M, et al. Cross-sectional review of effects of laparoscopic sleeve gastrectomy at 1, 3, and 5 years. Surg Obes Relat Dis 2011;7:714-19
   PubMed Web of Science ®Google Scholar
• Nguyen NT, Slone JA, Nguyen XM, et al. A prospective randomized trial of laparoscopic gastric bypass versus laparoscopic adjustable gastric banding for the treatment of morbid obesity: outcomes, quality of life, and costs. Ann Surg 2009;250:631-41
   PubMed Web of Science ®Google Scholar
• Angrisani L, Cutolo PP, Formisano G, et al. Laparoscopic adjustable gastric banding versus roux-en-y gastric bypass: 10-year results of a prospective randomized trial. Surg Obes Relat Dis 2013;9:405-13
   PubMed Web of Science ®Google Scholar